Hypophosphatasia: Enzyme Replacement Therapy (Asfotase Alfa) Decreases TNSALP Substrate Accumulation And Improves Functional Outcomes In Affected Adolescents And Adults

Authors

  • M P Whyte Shriners Hospital for Children
  • P S Kishnani Duke University
  • C R Greenberg Shriners Hospital for Children
  • K Madson Shriners Hospital for Children
  • K Mack Shriners Hospital for Children
  • T Weber Duke University
  • A Mhanni University of Manitoba
  • H Plotkin Cambridge, MA
  • N Kreher
  • H Landy

Abstract

-

Author Biographies

M P Whyte, Shriners Hospital for Children

Shriners Hospital for Children, St. Louis, MO

P S Kishnani, Duke University

Duke University, Durham , North Carolina

C R Greenberg, Shriners Hospital for Children

Shriners Hospital for Children, St. Louis, MO

K Madson, Shriners Hospital for Children

Shriners Hospital for Children, St. Louis, MO

K Mack, Shriners Hospital for Children

Shriners Hospital for Children, St. Louis, MO

T Weber, Duke University

Duke University, Durham, NC

A Mhanni, University of Manitoba

University of Manitoba, Winnipeg

H Plotkin, Cambridge, MA

Alexion Pharmaceuticals, Cambridge, MA

N Kreher

Alexion Pharmaceuticals, Cambridge, MA

H Landy

Alexion Pharmaceuticals, Cambridge, MA

Published

2012-07-31